Hematology

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.

At COMy 2025, researchers highlighted barriers to EMA-approved CAR-T cell therapy access due to age, comorbidities, and inequality.

A study presented at COMy 2025 found that dual MRD testing with bone marrow flow cytometry and PET/CT imaging better predicts progression-free survival in patients with multiple myeloma after autologous stem cell transplantation.

Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.

A large-scale study involving over 28,000 women has demonstrated the effectiveness of next-generation sequencing (NGS) in identifying thalassemia carriers and preventing severe cases of the genetic blood disorder…

Latest data from the global ALLELE study confirms the benefits of tabelecleucel cell therapy for transplant recipients who go on to develop a rare but often fatal blood cancer.

THE 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city of…